Reported Jan 22, 2014 · Terminated

DOXEPIN HCL Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 49884022201

Aidapak Services, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Aidapak Services, LLC · 14301 Se 1st St · Vancouver, WA · 98684-3501

Is this the product you have?

  • DOXEPIN HCL Capsule, 150 mg, Rx only
  • Distributed byAidaPak Service, LLC, NDC 49884022201
Lot codes and dates
  • DOXEPIN HCL, Capsule, 150
  • mg has the following code PedigreeAD46312_10
  • EXP5/16/2014
Amount recalled
100 Capsules

This recall covers 273 products

The agency filed one notice per product. You are reading one of them; the other 272 are below.

260 more are in the archive.

Where it was sold

Why it was recalled

Labeling: Label Mixup; DOXEPIN HCL Capsule, 150 mg may be potentially mislabeled as VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD46312_7, EXP: 5/16/2014.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Aidapak Services, LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 7, 2014 · Data as of Sep 19, 7:04 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.